Search

everythinglearnresearchcommunity

for

Search:↓

Dermatologists need to understand hair products to treat hair and scalp issues better.

Male and female skin differ due to hormones, affecting conditions like hair loss, acne, and skin cancer, and suggesting a need for gender-specific treatments.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Taxane chemotherapy can cause skin, hair, and nail side effects, which are often under-reported and can affect patient quality of life.

The document concludes that understanding hair structure is key to diagnosing hair abnormalities and recommends gentle hair care for management.

Isotretinoin effectively treats severe acne and similar conditions, but has common, mostly reversible side effects, requiring careful patient monitoring.

Skin surface lipids are important for skin health and altering them could help prevent aging and treat skin conditions.

Male hormones and their receptors play a key role in hair loss and skin health, with potential new treatments being explored.

Androgens can both stimulate and cause hair loss, and understanding their effects is key to treating hair disorders.

Minoxidil and finasteride effectively treat hair loss.

To diagnose hair loss, use a systematic approach including history, exams, and tests.

Hair loss from Telogen Effluvium usually gets better within 6 months after addressing the cause.

Acne is caused by genetics, diet, hormones, and bacteria, with treatments not yet curative.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Nanotechnology in dermatology shows promise for better drug delivery and treatment effectiveness but requires more safety research.

Minoxidil breakdown varies by enzymes, affecting hair loss treatment effectiveness.

Different methods of preparing Platelet-Rich Plasma (PRP) can affect wound healing and hair regrowth in plastic surgery. Using a kit with specific standards helps isolate PRP that meets quality criteria. Non-Activated PRP and Activated PRP have varying effects depending on the tissue and condition treated. For hair regrowth, Non-Activated PRP increased hair density more than Activated PRP. Both treatments improved various aspects of scalp health.

Minoxidil absorbs poorly through skin, with low risk of side effects at 1-2% concentration.

Excessive hair growth can be assessed by history, exam, and blood tests, and treated with medication like dexamethasone, birth control pills, and spironolactone.

The conclusion is that hirsutism should be diagnosed and treated because it affects quality of life and may signal other health problems.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

Female pattern hair loss involves hormonal factors, genetics, and may be linked to low ferritin levels.

Kids with early graying hair often have low levels of calcium, ferritin, and vitamin D3.

Teen hair loss common in boys, linked to family history and mild symptoms.

Scalp cooling is the most effective FDA-approved method to prevent chemotherapy-induced hair loss, but more research is needed for other treatments.

Alopecia areata is an autoimmune hair loss condition treated with corticosteroids, and histologic confirmation is the best diagnosis method.

Diagnosing hair loss disorders needs clinical, dermoscopic, and histological differences, and checking menstrual cycle, weight changes, drug therapy, and nail changes.

Certain fats in the skin help control inflammation and health, and changing these fats through diet or supplements might treat skin inflammation.

There is no significant link between male pattern baldness and insulin resistance.

Certain Chinese herbs, especially Cacumen platycladi, can promote hair regrowth and reduce hair loss-related hormone levels in mice.